
Forma Therapeutics Holdings Inc is a biotechnology business based in the US. Forma Therapeutics shares (FMTX) are listed on the NASDAQ and all prices are listed in US Dollars. Forma Therapeutics employs 176 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Forma Therapeutics
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – FMTX – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Our top pick for
Beginners

Our top pick for
Building a portfolio

Our top pick for
Advanced traders

Forma Therapeutics stock price (NASDAQ: FMTX)
Use our graph to track the performance of FMTX stocks over time.Forma Therapeutics shares at a glance
Latest market close | $7.12 |
---|---|
52-week range | $4.95 - $26.61 |
50-day moving average | $6.65 |
200-day moving average | $12.73 |
Wall St. target price | $40.29 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-3.82 |
Buy Forma Therapeutics shares from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Forma Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Forma Therapeutics price performance over time
Historical closes compared with the close of $7.12 from 2022-07-01
1 week (2022-06-24) | 1.28% |
---|---|
1 month (2022-06-03) | 23.18% |
3 months (2022-04-01) | -28.73% |
6 months (2022-01-03) | -51.53% |
1 year (2021-07-02) | -71.30% |
---|---|
2 years (2020-07-02) | -85.27% |
3 years (2019-06-29) | N/A |
5 years (2017-06-29) | N/A |
Forma Therapeutics financials
Revenue TTM | $7.4 million |
---|---|
Gross profit TTM | $-125,661,000 |
Return on assets TTM | -19.55% |
Return on equity TTM | -33.62% |
Profit margin | 0% |
Book value | $9.66 |
Market capitalisation | $353.7 million |
TTM: trailing 12 months
Forma Therapeutics share dividends
We're not expecting Forma Therapeutics to pay a dividend over the next 12 months.
Forma Therapeutics share price volatility
Over the last 12 months, Forma Therapeutics's shares have ranged in value from as little as $4.95 up to $26.61. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Forma Therapeutics's is 0.4367. This would suggest that Forma Therapeutics's shares are less volatile than average (for this exchange).
Forma Therapeutics overview
Forma Therapeutics Holdings, Inc. , a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobinopathies; and FT-7051 for the treatment of metastatic castration-resistant prostate cancer. The company is also developing Olutasidenib, a selective inhibitor for cancers with isocitrate dehydrogenase 1 gene mutations, which is in Phase II trial for the treatment of relapsed/refractory acute myeloid leukemia and Phase I trial to treat glioma; and FT-8225, a liver-targeted fatty-acid synthase inhibitor designed to block de novo lipogenesis in the liver. Forma Therapeutics Holdings, Inc. was founded in 2007 and is headquartered in Watertown, Massachusetts. .
Forma Therapeutics in the news
Forma Therapeutics Announces Appointment of New Executive Team Members
Can Forma Therapeutics Holdings, Inc. (FMTX) Climb 536% to Reach the Level Wall Street Analysts Expect?
Bears are Losing Control Over Forma Therapeutics Holdings, Inc. (FMTX), Here's Why It's a 'Buy' Now
Frequently asked questions
What percentage of Forma Therapeutics is owned by insiders or institutions?Currently 5.115% of Forma Therapeutics shares are held by insiders and 90.95% by institutions. How many people work for Forma Therapeutics?
Latest data suggests 176 work at Forma Therapeutics. When does the fiscal year end for Forma Therapeutics?
Forma Therapeutics's fiscal year ends in December. Where is Forma Therapeutics based?
Forma Therapeutics's address is: 300 North Beacon Street, Watertown, MA, United States, 02472 What is Forma Therapeutics's ISIN number?
Forma Therapeutics's international securities identification number is: US34633R1041
More guides on Finder
-
How to buy Intchains Group (ICG) stock when it goes public
Everything we know about the Intchains Group IPO, plus information on how to buy in.
-
How to buy Biostage (BSTG) stock when it goes public
Everything we know about the Biostage IPO, plus information on how to buy in.
-
How to buy Wang & Lee Group (WLGS) stock when it goes public
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
-
How to buy OptMed (OMED) stock when it goes public
Everything we know about the OptMed IPO, plus information on how to buy in.
-
How to buy Lichen China (LICN) stock when it goes public
Everything we know about the Lichen China IPO, plus information on how to buy in.
-
How to buy LeeWay Services stock when it goes public
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
-
How to buy Nano Labs (NA) stock when it goes public
Everything we know about the Nano Labs IPO, plus information on how to buy in.
-
How to buy Warrantee (WRNT) stock when it goes public
Everything we know about the Warrantee IPO, plus information on how to buy in.
-
How to buy Treasure Global (TGL) stock when it goes public
Everything we know about the Treasure Global IPO, plus information on how to buy in.
-
How to buy BIOLIFE4D (SAVU) stock when it goes public
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.
Ask an Expert